Veterinary Medicines

Gallivac IB88 neo, bruistablet voor suspensie voor kippen

Authorised
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Download as PDF

Product identification

Medicine name:
Gallivac IB88 neo, bruistablet voor suspensie voor kippen
Active substance:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
    4.00
    log 10 50% embryo infective dose
    /
    1.00
    dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 116422
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/06/2025
Download